Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study-Reference-Cited by-同舟云学术

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

Published:2017-07-19 Issue:4 Volume:177 Page:1014-1023
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Reich K.¹²^ORCID,Pinter A.³,Lacour J.P.⁴,Ferrandiz C.⁵,Micali G.⁶,French L.E.⁷,Lomaga M.⁸,Dutronc Y.⁹,Henneges C.⁹,Wilhelm S.⁹,Hartz S.⁹,Paul C.¹⁰^ORCID,

Affiliation:

1. Dermatologikum Hamburg; Stephansplatz 5 20354 Hamburg Germany

2. Georg-August-University; Göttingen Germany

3. Department of Dermatology, Venereology, and Allergology; University Clinic Frankfurt; Frankfurt am Main Germany

4. Department of Dermatology; University Hospital of Nice; Nice France

5. Servicio de Dermatología; Hospital Universitario Germans Trias i Pujol; Universitat Autónoma de Barcelona; Badalona Barcelona Spain

6. Dermatology Clinic; University of Catania; University Hospital Policlinico-Vittorio Emanuele; Catania Sicily Italy

7. Department of Dermatology; University of Zurich Hospital; Zurich Switzerland

8. DermEdge Research; Mississauga ON Canada

9. Eli Lilly and Company; Indianapolis IN U.S.A.

10. Dermatology Department; CHU; Paul Sabatier University; Toulouse France

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15666/fullpdf

Reference29 articles.

1. Immunology of psoriasis;Lowes;Annu Rev Immunol,2014

2. The IL-23/Th17 axis in the immunopathogenesis of psoriasis;Cesare;J Invest Dermatol,2009

3. Role of IL-17 in psoriasis and psoriatic arthritis;Raychaudhuri;Clin Rev Allergy Immunol,2013

4. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation;Cai;Immunity,2011

5. Dermal γδ T cells - a new player in the pathogenesis of psoriasis;Cai;Int Immunopharmacol,2013

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-Analysis;Journal of Clinical Medicine;2024-08-29

2. The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations;Expert Opinion on Biological Therapy;2024-08-02

3. Research trends and hotspots in biologics for plaque psoriasis: A bibliometric study from 2004 to 2023;Heliyon;2024-08

4. Performance of two large language models for data extraction in evidence synthesis;Research Synthesis Methods;2024-06-19

5. Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity;Dermatology and Therapy;2024-05-30